Title: Conference on Biomedical R&D for Public Health in India
Date: 13-14 August 2018
Venue: Vivanta Ambassador Hotel, New Delhi, India
Organizers: The South Centre, the Council for Scientific and Industrial Research, the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL)
Title: Side Event to the 71st World Health Assembly, on Access to Medicines: Overcoming Obstacles created by monopolies – Essential to UHC and the 2030 Agenda
Date: 25 May 2018
Venue: Room VIII, Palais des Nations, Geneva
Organizers: Missions of Brazil, India, Morocco, Senegal, and Thailand, with the support of the South Centre
Title: Fourth Annual WHO-NGO Dialogue in Geneva
Date: 9 May 2018
Venue: The South Centre, Geneva
Organizers: The South Centre, Third World Network and ReAct
Title: Consultations with the United Nations Interagency Coordination Group on Antimicrobial Resistance (IACG) Subgroup 4 on Innovation and Access
Date: 8 May 2018
Venue: The South Centre, Geneva
Organizers: The South Centre, Third World Network and ReAct
Title: Charting a Future Free from the Fear of Untreatable Infections
Date: 7-9 May 2018
Venue: The South Centre, Geneva
Organizers: The South Centre, Third World Network and ReAct
Major Outcomes of the 71st Session of the World Health Assembly of WHO
By Nirmalya Syam and Mirza Alas
The 71st session of the World Health Assembly (WHA) of the World Health Organization (WHO) took place from 21 to 26 May 2018 in Geneva, Switzerland. The Assembly adopted several decisions and resolutions including the adoption of the General Programme of Work (GPW) of WHO for the period 2019-2023, as well as decisions on addressing access to medicines and vaccines and their global shortage, and the recommendations of an overall programme review of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI). (more…)
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of May 2018.
Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C
Por Dr. Carlos M. Correa y Dr. Germán Velásquez
El acceso a medicamentos está fuertemente condicionado por su precio y por los mecanismos de financiamiento que pueden aplicarse en cada país. […] Un factor determinante en la fijación del precio de los medicamentos es el grado de competencia existente en una particular clase terapéutica, la que a su vez es influenciada por la existencia o no de derechos de propiedad intelectual, como patentes de invención.
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of April 2018.
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of March 2018.
Title: The Global South Facing a New Era of Unilateralism and Protectionism: Challenges and Prospects
Date: Tuesday, 17 April 2018, 13h00-15h00
Venue: Room XXIII, Palais des Nations, Geneva
Organizers: The South Centre
South Centre Statement at the Meeting of Ministers of Health of the Member States of the Non-Aligned Movement
The South Centre reiterates its commitment to support the Non-Aligned countries so that there is close and effective cooperation among developing countries to strengthen a global health agenda. WHO was created as an international public agency in the service of global health. Recovering and reinforcing this role should be the work of all.
